AI Article Synopsis

Article Abstract

In the evolving landscape of biomedical research, the convergence of molecular biology and translational medicine has ushered in a new era of pharmaceutical innovation. This paradigm shift, characterized by significant advances in targeted therapies and gene editing, emphasizes the critical role of integrating academic research - and academic researchers - within industry settings. Contemporary innovation models are moving beyond traditional, corporation-centered frameworks, adopting more open, collaborative approaches. Here, we discuss the challenges and solutions brought about by this new direction in pharma innovation and describe the BioMed X innovation model, a unique open innovation approach that has been growing continuously over the past ten years.

Download full-text PDF

Source
http://dx.doi.org/10.1007/164_2024_729DOI Listing

Publication Analysis

Top Keywords

innovation
6
innovation interface
4
interface academia
4
academia industry
4
industry biomed
4
biomed model
4
model evolving
4
evolving landscape
4
landscape biomedical
4
biomedical convergence
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!